Lineage Cell Therapeutics Earnings Preview
Portfolio Pulse from Benzinga Insights
Lineage Cell Therapeutics (LCTX) is set to release its quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.04. The company's past performance shows a pattern of share price drops following earnings beats. The stock is currently trading at $1.42, down 4.58% over the last 52-week period.
August 09, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Lineage Cell Therapeutics is expected to report an EPS of $-0.04. The company's stock has historically dropped following earnings beats. The stock is currently down 4.58% over the last 52 weeks.
The company's stock has historically dropped following earnings beats, which could indicate a pattern of investor disappointment despite better-than-expected results. The stock's negative performance over the past year also suggests a lack of investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100